TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG. |. OTCQB: PSYGF) (Psyence or the Company), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that it has entered into a partnership with Eden Labs LLC, (“Eden Labs”) a product development and extraction technology company that has developed…

Source

Previous articleApex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial
Next articlePharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome